Ocugen has skin in the Covid-19 vaccine game. But the company faces long odds on its partnership providing a long-term boost for OCGN stock.
Ocugen Faces Long Odds Before Gaining From Its Covid-19 Support Role
2021-05-21T09:01:51-04:00May 21st, 2021|
Related Posts
-
Worst-ever interviews: ‘They told us to crawl and moo’
May 3rd, 2024 -
Have the wheels come off for Tesla?
May 3rd, 2024 -
Buy Now or Regret Later: 3 Tech Stocks Ready to Take Off
May 3rd, 2024